KMT2A and leukemia: Compounds MI-503, MI-538, MI-1481, and MI-3454 effectively suppressed the growth of leukemic cells with MLL-r in vitro and in vivo and did not affect the growth of leukemia without MLL mutation and normal hematopoiesis.